| |
| |
|
| Insider
Information: |
Daly David |
| Relationship: |
Director |
| City: |
San Juan Capistrano |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
1,017,884 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$22,949 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
1,017,884 |
|
|
| Total
Value |
$22,949 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clarient Inc |
CLRT |
Chief Commercial Officer |
2010-12-22 |
0 |
2008-01-30 |
0 |
Premium* |
|
|
Foundation Medicine, Inc. |
FMI |
Chief Commercial Officer |
2017-08-09 |
116,261 |
2014-12-05 |
0 |
Premium* |
|
|
Singular Genomics Systems, Inc. |
OMIC |
Officer |
2021-05-26 |
900,000 |
|
0 |
Premium* |
|
|
NeoGenomics Inc |
NEO |
Director |
2021-11-10 |
1,623 |
2021-11-10 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NEO |
NeoGenomics Inc |
Director |
– • – |
2021-11-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,623 |
1,623 |
0 |
- |
|
| OMIC |
Singular Genomics Systems... |
President and Chief OperatingO |
• – – |
2021-05-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
900,000 |
|
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2017-08-09 |
4 |
S |
$39.50 |
$1,851,444 |
D/D |
(46,872) |
116,261 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2017-08-09 |
4 |
OE |
$22.24 |
$1,042,433 |
D/D |
46,872 |
163,133 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2017-07-06 |
4 |
S |
$38.84 |
$245,313 |
D/D |
(6,316) |
116,261 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2017-06-01 |
4 |
S |
$38.30 |
$21,257 |
D/D |
(555) |
122,577 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2017-05-01 |
4 |
A |
$35.80 |
$878,890 |
D/D |
24,550 |
123,132 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2017-04-03 |
4 |
S |
$31.96 |
$66,157 |
D/D |
(2,070) |
98,582 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2017-01-04 |
4 |
S |
$18.49 |
$43,821 |
D/D |
(2,370) |
101,193 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2017-01-03 |
4 |
S |
$17.41 |
$47,477 |
D/D |
(2,727) |
103,563 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2016-12-01 |
4 |
S |
$19.95 |
$11,252 |
D/D |
(564) |
106,290 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2016-10-04 |
4 |
S |
$23.65 |
$48,364 |
D/D |
(2,045) |
106,854 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2016-09-01 |
4 |
S |
$20.48 |
$11,284 |
D/D |
(551) |
108,899 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2016-07-05 |
4 |
S |
$18.26 |
$38,894 |
D/D |
(2,130) |
109,450 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2016-07-01 |
4 |
S |
$17.39 |
$50,048 |
D/D |
(2,878) |
111,580 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2016-06-03 |
4 |
S |
$21.66 |
$10,224 |
D/D |
(472) |
114,458 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2016-04-01 |
4 |
A |
$18.25 |
$1,277,500 |
D/D |
70,000 |
114,930 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2016-03-01 |
4 |
S |
$15.14 |
$10,613 |
D/D |
(701) |
44,930 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2015-12-01 |
4 |
S |
$16.78 |
$42,946 |
D/D |
(2,559) |
45,631 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2015-07-15 |
4 |
A |
$32.74 |
$759,241 |
D/D |
23,190 |
48,190 |
0 |
- |
|
| FMI |
Foundation Medicine, Inc. |
Chief Commercial Officer |
• – – |
2014-12-05 |
4 |
A |
$22.24 |
$556,000 |
D/D |
25,000 |
25,000 |
0 |
- |
|
| CLRT |
Clarient Inc |
Chief Commercial Officer |
• – – |
2010-12-22 |
4 |
D |
$5.00 |
$791,670 |
D/D |
(158,334) |
0 |
0 |
- |
|
| CLRT |
Clarient Inc |
Chief Commercial Officer |
• – – |
2010-12-17 |
4 |
D |
$5.00 |
$479,875 |
D/D |
(95,975) |
158,334 |
0 |
- |
|
| CLRT |
Clarient Inc |
Sr. VP of Commercial Ops |
• – – |
2010-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
254,309 |
0 |
- |
|
| CLRT |
Clarient Inc |
Sr. VP of Commercial Ops |
• – – |
2010-06-01 |
4 |
AS |
$2.96 |
$4,736 |
D/D |
(1,600) |
154,309 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
